Bromide

Bromide

SCHEMBL1461850

Cc1cc[n+](Cc2ccccc2)c2ccccc12.[Br-]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CHKA known ✓ P35790 6/20 0.54
KDM4E B2RXH2 2/20 0.68
LMNA P02545 1/20 0.68
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
POLB P06746 1/20 0.59
RECQL P46063 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1363019 0.98 KDM4E (0.69) KDM4ELMNANPC1RAB9APOLB
Bromide SCHEMBL6246487 0.85 KDM4E (0.63) KDM4ELMNANPC1RAB9APOLB
SCHEMBL12330785 0.85 KDM4E (0.55) KDM4ELMNANPC1RAB9APOLB
SCHEMBL12330996 0.85 KDM4E (0.58) KDM4ELMNANPC1RAB9APOLB
Bromide SCHEMBL6245928 0.81 NPC1 (0.62) KDM4ELMNANPC1RAB9APOLB
Bromide SCHEMBL2482814 0.80 KDM4E (0.59) KDM4ELMNANPC1RAB9APOLB
SCHEMBL9934703 0.80 KDM4E (0.58) KDM4ELMNANPC1RAB9APOLB
Bromide SCHEMBL3324489 0.79 CHKA (0.54) KDM4ENPC1RAB9ACHKA
SCHEMBL1476988 0.78 KDM4E (0.57) KDM4ELMNANPC1RAB9APOLB
SCHEMBL23230144 0.77 NPC1 (0.52) KDM4ELMNANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2982245-B1 CYANINE DYES FOR LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS ENZO LIFE SCIENCES INC (US) 2018-08-08 EP disclosed
EP-1885718-B1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE LIFE TECHNOLOGIES CORP (US) 2017-03-15 EP disclosed
EP-2607431-B1 Cyanine dye compounds LIFE TECHNOLOGIES CORP (US) 2016-08-24 EP disclosed
US-9366676-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2016-06-14 US disclosed
EP-2982245-A1 LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS, NOVEL COMPOSITIONS, METHODS AND KITS Enzo Life Sciences, Inc. (US) 2016-02-10 EP disclosed
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use MOLECULAR PROBES, INC. 2015-11-05 US disclosed
EP-2381783-B1 LABELING OF TARGET MOLECULES, IDENTIFICATION OF ORGANELLES AND OTHER APPLICATIONS, NOVEL COMPOSITIONS, METHODS AND KITS ENZO LIFE SCIENCES INC (US) 2015-09-02 EP disclosed
US-9115397-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2015-08-25 US disclosed
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use LIFE TECHNOLOGIES CORP (US) 2015-01-01 US disclosed
US-8865904-B2 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use Life Technologies Corporation (US) 2014-10-21 US disclosed
WO-2006124816-A1 FLUORESCENT CHEMICAL COMPOUNDS HAVING HIGH SELECTIVITY FOR DOUBLE STRANDED DNA, AND METHODS FOR THEIR USE MOLECULAR PROBES, INC. (US) 2006-11-23 WO disclosed
EP-1720944-A2 CYANINE DYE COMPOUNDS Molecular Probes Inc. (US) 2006-11-15 EP disclosed
US-20050214810-A1 Cyanine dye compounds MOLECULAR PROBES, INC. 2005-09-29 US disclosed
EP-1303751-B1 DYES AND METHODS OF DETECTION OF NUCLEIC ACID IN IMMATURE RED BLOOD CELLS COULTER INT CORP (US) 2005-08-10 EP disclosed
WO-2005056689-A2 CYANINE DYE COMPOUNDS MOLECULAR PROBES, INC. (US) 2005-06-23 WO disclosed
EP-1303751-A4 DYES AND METHODS OF DETECTION OF NUCLEIC ACID IN IMMATURE RED BLOOD CELLS COULTER INT CORP (US) 2003-05-28 EP disclosed
EP-1303751-A1 DYES AND METHODS OF DETECTION OF NUCLEIC ACID IN IMMATURE RED BLOOD CELLS Coulter International Corp. (US) 2003-04-23 EP disclosed
US-6551831-B2 Detection of nucleic acids in red blood cells by flow cytometry by employing fluorescent, nucleic acid binidng cyanine dye COULTER INTERNATIONAL CORP. 2003-04-22 US disclosed
US-20020037589-A1 Dyes and methods of detection of nucleic acid in immature red blood cells COULTER INTERNATIONAL CORP. 2002-03-28 US disclosed
WO-2001086264-A1 DYES AND METHODS OF DETECTION OF NUCLEIC ACID IN IMMATURE RED BLOOD CELLS COULTER INTERNATIONAL CORP. (US) 2001-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050214810-A1 Cyanine dye compounds POLL, XPA, DUT CHKA 803/4885KDM4E 801/4885LMNA 85/4885
US-20150316558-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 CHKA 2846/4885KDM4E 2506/4885LMNA 473/4885
US-20150004597-A1 Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use POLRMT, DNA2, NSUN2 CHKA 2846/4885KDM4E 2506/4885LMNA 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.